Filing Details
- Accession Number:
- 0001288123-10-000012
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2010-01-22 12:00:00
- Reporting Period:
- 2010-01-19
- Filing Date:
- 2010-01-22
- Accepted Time:
- 2010-01-22 14:30:22
- Original Submission Date:
- 2010-01-21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1098972 | Antigenics Inc | AGEN | Biological Products, (No Disgnostic Substances) (2836) | 061562417 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1369453 | Kerry Wentworth | C/O Antigenics Inc. 162 Fifth Avenue, Suite 2100 New York NY 10010 | Vp, Clin, Reg & Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-01-19 | 136,421 | $0.90 | 242,853 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2010-01-20 | 102,316 | $0.85 | 140,537 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents settlement of restricted stock granted on January 19, 2010 in lieu of an annual cash bonus for 2009 performance.
- Represents the sale of shares obtained from the vesting of restricted stock granted on January 19, 2010 in lieu of an annual cash bonus for 2009 performance. This sale has been made through a Rule 10b5-1 trading plan.
- This amended filing is made to properly reflect the shares as disposed. These shares were obtained from the vesting of restricted stock granted on January 19, 2010 in lieu of an annual cash bonus for 2009 performance. This sale has been made through a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
